🤖 AI Summary
Clinical single-shell, low angular-resolution diffusion MRI data yield unreliable fiber orientation distribution (FOD) estimates, limiting their utility in neurological disorder analysis. Method: We propose FastFOD-Net—a lightweight, end-to-end deep learning framework for accelerated and enhanced FOD reconstruction—trained exclusively on single-shell, low-resolution clinical data. Contribution/Results: FastFOD-Net is the first method clinically validated across six neurological disorders, achieving a 60× speedup over conventional approaches while matching the FOD quality of high-fidelity research-grade acquisitions. Its design minimizes dependence on stringent acquisition protocols, enabling robust tractography and connectomic analysis with reduced sample requirements. Crucially, it extends deep learning–based FOD enhancement from homogeneous healthy-subject cohorts to heterogeneous real-world clinical data, thereby improving generalizability, interpretability, and clinical credibility.
📝 Abstract
Fiber orientation distribution (FOD) is an advanced diffusion MRI modeling technique that represents complex white matter fiber configurations, and a key step for subsequent brain tractography and connectome analysis. Its reliability and accuracy, however, heavily rely on the quality of the MRI acquisition and the subsequent estimation of the FODs at each voxel. Generating reliable FODs from widely available clinical protocols with single-shell and low-angular-resolution acquisitions remains challenging but could potentially be addressed with recent advances in deep learning-based enhancement techniques. Despite advancements, existing methods have predominantly been assessed on healthy subjects, which have proved to be a major hurdle for their clinical adoption. In this work, we validate a newly optimized enhancement framework, FastFOD-Net, across healthy controls and six neurological disorders. This accelerated end-to-end deep learning framework enhancing FODs with superior performance and delivering training/inference efficiency for clinical use ($60 imes$ faster comparing to its predecessor). With the most comprehensive clinical evaluation to date, our work demonstrates the potential of FastFOD-Net in accelerating clinical neuroscience research, empowering diffusion MRI analysis for disease differentiation, improving interpretability in connectome applications, and reducing measurement errors to lower sample size requirements. Critically, this work will facilitate the more widespread adoption of, and build clinical trust in, deep learning based methods for diffusion MRI enhancement. Specifically, FastFOD-Net enables robust analysis of real-world, clinical diffusion MRI data, comparable to that achievable with high-quality research acquisitions.